Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Yvoir

Ghent

Los Angeles

Goshen

Gauting

Redmond

Glendale

Duarte

La Verne

San Francisco

Port Saint Lucie

Tampa

Chicago

Maywood

Louisville

Grand Rapids

Saint Cloud

St Louis

Las Vegas

Columbus

Bend

Portland

Chattanooga

Knoxville

Nashville

Dallas

Salt Lake City

Arlington

Seattle

Brasschaat

Brussels

Charleroi

Charleroi

Liège

Hamilton

Kingston

Toronto

Lévis

Montreal

Ostava-Poruba

Ostrava-Poruba

Esslingen am Neckar

Gerlingen

Heidelberg

Ulm

Villingen-Schwenningen

Munich

Frankfurt am Main

Immenhausen

Cologne

Rheine

Mainz

Halle

Großhansdorf

Giessen

Székesfehérvár

Győr

Szolnok

Tatabánya

Meldola

Sora

Lecco

Benevento

Bologna

Cremona

Faenza

Genova

Milan

Napoli

Perugia

Ravenna

Rimini

Roma

Rozzano

Torun

Otwock

Gdansk

Szczecin

Krakow

Prabuty

Warsaw

A Coruña

Seville

Valencia

Alicante

Barcelona

Burgos

Madrid

Manresa

Palma de Mallorca

Valencia

Zaragoza

Stevenage

London

Metropolitan Borough of Wirral

Northwood

Rickmansworth

Southampton